Skip to content

Bright Horizons Family Solutions BFAM Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Community Financial System logo
Community Financial SystemCBU
SLM logo
SLMSLM

Other financials

Income statement

See full
Revenue$712.2M+7.0%
Gross profit$163.5M+5.0%
Operating income$64.9M+4.3%
Net income$34.1M-10.4%
EPS (diluted)$0.62-6.1%

Balance sheet

See full
Cash & equivalents$136.7M+10.3%
Total debt$1.7B-3.4%
Total equity$1.1B-13.5%
Total assets$3.8B-0.8%

Cash flow

See full
Operating cash flow$107.7M+25.0%
CapEx$20.1M+32.1%
Free cash flow$87.6M+23.5%

Valuation

See full
Market cap$3.46B-37.9%

Profitability

See full
Gross margin23.7%+0.2pp
Operating margin10.6%+0.8pp
Net margin6.3%+0.4pp
FCF margin8.6%-4.8pp

Returns & leverage

See full
Return on equity15.3%+2.7pp
Debt / equity1.5×+0.2×
Current ratio0.5×-0.1×

Where this comes from

Reported directly by Bright Horizons Family Solutions in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Bright Horizons Family Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bright Horizons Family Solutions's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bright Horizons Family Solutions's common stock, shares authorized (in shares)?
Bright Horizons Family Solutions (BFAM) reported common stock, shares authorized (in shares) of $475M in Q1 2026.
How has Bright Horizons Family Solutions's common stock, shares authorized (in shares) changed year-over-year?
Bright Horizons Family Solutions's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $475M to $475M.
What is the long-term trend for Bright Horizons Family Solutions's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Bright Horizons Family Solutions's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $475M to $475M.